FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug-Coated Peripheral Transluminal Angioplasty Catheter
PMA: P190008
·
Supplement: S028
·
Decision Apr 23, 2024
Classifications
1
FEI Numbers
7
Registration Numbers
7
Basic Information
- Device Name
- Drug-Coated Peripheral Transluminal Angioplasty Catheter
- Trade Name
- IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
- PMA Number
- P190008
- Supplement Number
- S028
- Device Class
- FDA Class 3
- Product Code
- PRC
- Generic Name
- Drug-coated peripheral transluminal angioplasty catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- April 23, 2024
- Date Received
- October 26, 2023
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Labeling Change - PAS
- Expedited Review
- N
Advisory Committee Statement
Approval for labeling changes to include the final study results of the IN.PACT AV Access IDE Cohort Post Approval Study
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| PRC | Drug-Coated Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |